Opinions
Andrey Omelchak
dentalcorp Holdings
DNTL-T
WEAK BUY
Dec 03, 2024
$8.910
Stock price when the opinion was issued
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
BUY
Their future looks strong. They've been acquiring dental offices of various sizes. The costs of dental track inflation, so there is increased revenues from this sector. People need their teeth to be look after regularly, so dental won't be impacted much by a recession. However, interest rates do pressure this sector. DNTL has lots of runway in Canada as well as the U.S, to expand.
Healthcare
BUY ON WEAKNESS
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research.
DNTL is still getting into its acquisition and roll-out strategy, and currently trades at an OK valuation.
The company has a strong equity position of $1.8 billion on a $1.6B market cap, although $2.1B of its assets are in goodwill, which can change quickly if an impairment charge takes place.
Revenue growth has been averaging in the 20%+ range, and it generates positive free cash flows which is mostly puts towards acquisitions.
We would like to see the company maintain or grow its current sales growth rates, and increase its profitability before stepping in here, but largely the company is on a decent trajectory.
Unlock Premium - Try 5i Free
Healthcare
RISKY
Advertising
Over time, expects it to be acquired by a big US player. Has been quite diligent not overpaying for acquisitions. Difficult to buy as many practices as they'd like. Pretty well run. Margins can increase step by step over time. Doesn't expect any big transformational news. Leverage is too elevated for his liking. Stable, predictable business.